Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1975 1
1979 1
1981 2
1982 1
1986 1
1987 1
1988 5
1990 1
1991 2
1992 1
1993 6
1994 3
1995 3
1996 4
1997 4
1998 5
1999 6
2000 7
2001 6
2002 6
2003 6
2004 6
2005 6
2006 9
2007 9
2008 11
2009 11
2010 12
2011 11
2012 14
2013 14
2014 13
2015 29
2016 25
2017 30
2018 19
2019 21
2020 37
2021 31
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

345 results
Results by year
Filters applied: . Clear all
Page 1
Mitotic WNT signalling orchestrates neurogenesis in the developing neocortex.
Da Silva F, Zhang K, Pinson A, Fatti E, Wilsch-Bräuninger M, Herbst J, Vidal V, Schedl A, Huttner WB, Niehrs C. Da Silva F, et al. Among authors: vidal v. EMBO J. 2021 Oct 1;40(19):e108041. doi: 10.15252/embj.2021108041. Epub 2021 Aug 25. EMBO J. 2021. PMID: 34431536 Free PMC article.
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.
Duffaud F, Mir O, Boudou-Rouquette P, Piperno-Neumann S, Penel N, Bompas E, Delcambre C, Kalbacher E, Italiano A, Collard O, Chevreau C, Saada E, Isambert N, Delaye J, Schiffler C, Bouvier C, Vidal V, Chabaud S, Blay JY; French Sarcoma Group. Duffaud F, et al. Among authors: vidal v. Lancet Oncol. 2019 Jan;20(1):120-133. doi: 10.1016/S1470-2045(18)30742-3. Epub 2018 Nov 23. Lancet Oncol. 2019. PMID: 30477937 Clinical Trial.
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Among authors: vidal v. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
[Central venous access in interventional radiology].
Habert P, Hak JF, Di Bisceglie M, Bartoli A, Gaubert JY, Vidal V, Tradi F. Habert P, et al. Among authors: vidal v. Presse Med. 2019 Oct;48(10):1141-1145. doi: 10.1016/j.lpm.2019.10.013. Epub 2019 Oct 25. Presse Med. 2019. PMID: 31669005 Review. French.
Fenofibrate treatment for severe hypertriglyceridemia in dogs.
Miceli DD, Vidal VP, Blatter MFC, Pignataro OP, Castillo VA. Miceli DD, et al. Among authors: vidal vp. Domest Anim Endocrinol. 2021 Jan;74:106578. doi: 10.1016/j.domaniend.2020.106578. Epub 2020 Oct 8. Domest Anim Endocrinol. 2021. PMID: 33137654
Meat products as prebiotic food carrier.
Câmara AKFI, Paglarini CS, Vidal VAS, Dos Santos M, Pollonio MAR. Câmara AKFI, et al. Among authors: vidal vas. Adv Food Nutr Res. 2020;94:223-265. doi: 10.1016/bs.afnr.2020.06.009. Epub 2020 Jul 22. Adv Food Nutr Res. 2020. PMID: 32892834 No abstract available.
[The experience of medical students as peer tutors].
Godoy P J, Vidal V A, Illesca P M, Espinoza A E, Flores E L. Godoy P J, et al. Among authors: vidal v a. Rev Med Chil. 2021 May;149(5):765-772. doi: 10.4067/s0034-98872021000500765. Rev Med Chil. 2021. PMID: 34751330 Free article. Spanish.
[Imaging of mediastinal tumors].
Gaubert JY, Cohen F, Vidal V, Louis G, Moulin G, Bartoli JM, Jacquier A. Gaubert JY, et al. Among authors: vidal v. Rev Pneumol Clin. 2010 Feb;66(1):17-27. doi: 10.1016/j.pneumo.2009.12.011. Epub 2010 Feb 18. Rev Pneumol Clin. 2010. PMID: 20207292 Review. French.
345 results